Navigated three-dimensional T1-weighted gradient-echo sequence for gadoxetic acid liver magnetic resonance imaging in patients with limited breath-holding capacity

2014 ◽  
Vol 40 (2) ◽  
pp. 278-288 ◽  
Author(s):  
Jeong Hee Yoon ◽  
Jeong Min Lee ◽  
Eun Sun Lee ◽  
Jeehyun Baek ◽  
Sangwoo Lee ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Three Dimensional ◽  
Gadoxetic Acid ◽  
Breath Holding ◽  
Resonance Imaging ◽  
Gradient Echo ◽  
Liver Magnetic Resonance Imaging

Transient Severe Motion Artifact on Arterial Phase in Gadoxetic Acid–Enhanced Liver Magnetic Resonance Imaging

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Dong Wook Kim ◽  
Sang Hyun Choi ◽  
Taeyong Park ◽  
So Yeon Kim ◽  
Seung Soo Lee ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Motion Artifact ◽  
Gadoxetic Acid ◽  
Arterial Phase ◽  
Resonance Imaging ◽  
Liver Magnetic Resonance Imaging

scholarly journals Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging

2021 ◽  
Author(s):  
Dow-Mu Koh ◽  
Ahmed Ba-Ssalamah ◽  
Giuseppe Brancatelli ◽  
Ghaneh Fananapazir ◽  
M. Isabel Fiel ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Liver Disease ◽  
Magnetic Resonance ◽  
Gadoxetic Acid ◽  
Resonance Imaging ◽  
International Forum ◽  
Enhanced Mri ◽  
Consensus Statements ◽  
Liver Magnetic Resonance Imaging ◽  
Enhanced Imaging

Abstract Objectives The 9th International Forum for Liver Magnetic Resonance Imaging (MRI) was held in Singapore in September 2019, bringing together radiologists and allied specialists to discuss the latest developments in and formulate consensus statements for liver MRI, including the applications of gadoxetic acid–enhanced imaging. Methods As at previous Liver Forums, the meeting was held over 2 days. Presentations by the faculty on days 1 and 2 and breakout group discussions on day 1 were followed by delegate voting on consensus statements presented on day 2. Presentations and discussions centered on two main meeting themes relating to the use of gadoxetic acid–enhanced MRI in primary liver cancer and metastatic liver disease. Results and conclusions Gadoxetic acid–enhanced MRI offers the ability to monitor response to systemic therapy and to assist in pre-surgical/pre-interventional planning in liver metastases. In hepatocellular carcinoma, gadoxetic acid–enhanced MRI provides precise staging information for accurate treatment decision-making and follow-up post therapy. Gadoxetic acid–enhanced MRI also has potential, currently investigational, indications for the functional assessment of the liver and the biliary system. Additional voting sessions at the Liver Forum debated the role of multidisciplinary care in the management of patients with liver disease, evidence to support the use of abbreviated imaging protocols, and the importance of standardizing nomenclature in international guidelines in order to increase the sharing of scientific data and improve the communication between centers. Key Points • Gadoxetic acid–enhanced MRI is the preferred imaging method for pre-surgical or pre-interventional planning for liver metastases after systemic therapy. • Gadoxetic acid–enhanced MRI provides accurate staging of HCC before and after treatment with locoregional/biologic therapies. • Abbreviated protocols for gadoxetic acid–enhanced MRI offer potential time and cost savings, but more evidence is necessary. The use of gadoxetic acid–enhanced MRI for the assessment of liver and biliary function is under active investigation.

Sign in / Sign up

Export Citation Format

Share Document